Home
Therapeutic Areas
Contact
Filters
Clear Filters
Cancer Type
Cancer Type
Therapy Type
Therapy Type
Approval/Trial Stage
Approval/Trial Stage
Intervention Type
Intervention Type
Solid/Hematological
Solid/Hematological
Medical Need
Medical Need
Added Benefit (SMR)
Added Benefit (SMR)
Added Clinical Value rating (ASMR)
Added Clinical Value rating (ASMR)
Orphan Status
Orphan Status
Drug Name
Cancer Type
Therapy types
Approval/Trial Stage
Evérolimus (VOTUBIA®)
Brain, Central Nervous System
Targeted Therapy
Approved
Ruxolitinib (JAKAVI®)
Myelofibrosis
Targeted Therapy
Approved
pomalidomide (IMNOVID®)
Multiple myeloma
Immunomodulatory Agent
Approved
trametinib (MEKINIST®)
Melanoma
Targeted Therapy
Approved
cobimetinib (COTELLIC®)
Melanoma
Targeted Therapy
Approved
durvalumab (IMFINZI®)
Lung
Immunotherapy
Approved
apalutamide (ERLEADA®)
Prostate
Hormone Therapy
Approved
darolutamide (NUBEQA®)
Prostate
Hormone Therapy
Approved
tucatinib (TUKYSA®)
Breast
Targeted Therapy
Approved
azacitidine (ONUREG®)
Leukemia
Chemotherapy
Approved
Previous
Next